Skip to main content
Ingredients/Compound/Scutellaria Baicalensis

Scutellaria Baicalensis.

Read pending.Scutellaria Baicalensis is in the library; the clinical read is in the queue.

Research-backed compound with potential health benefits. Think of it as a cooling agent for an overactive mind and body.

250 to 500mgDaily amount10,025Studies read

Reviewed March 2026

SBCompound
Scutellaria BaicalensisIngredientMD
Category
Compound

What Scutellaria Baicalensis is, and what it does.

Does it work
Maybe. It has solid traditional use and emerging science. If you struggle with anxiety or chronic low-grade inflammation, it's a decent option to try.
How much to take
Look for extracts standardized to baicalin. 250-500mg of extract, once or twice a day, is a common starting point.
Time to feel it
Some people notice a mild settling within a few hours. Anything steadier, joint comfort included, builds over roughly two to six weeks of daily use.
The first dose
Probably nothing. Some people feel a mild calming effect within a few hours, but for most, it takes a few days to notice a real difference.
With regular use
After a few weeks, the main benefit is a more resilient stress response. You might feel more even-keeled. Some people report better sleep quality too.
How well tolerated
Generally well tolerated for short-term use. The biggest watch-out is potential liver stress at very high doses or with long-term use. Stick to recommended doses and cycle off it periodically.
How it feels
Subtle. It's not a drug. It's a gentle dialing-down of your internal stress signals. Like turning the volume down from 8 to 6.
The overlooked benefit
Baicalin only becomes absorbable once gut bacteria strip the sugar off it, so how much you get from a dose depends partly on your own microbiome.

250 to 500mg a day is where Scutellaria Baicalensis works.

How much to take a dayMedium confidence
250 to 500mg
Daily maintenanceThe everyday amount, and where most daily supplements sit. This is the one you take month after month.
1,500mgClinical territory. Trials run high on purpose, for a set number of weeks, against one measured outcome. Impressive to hit, and not what a daily product is for.
Above 2,000mgPast what the research covers. More capsules rather than more effect.
MORE EFFECT ↑0500mg1,500mg plateauDAILY DOSE →
The shaded band is where the dosing trials landed.

Source: Zhao et al., J Ethnopharmacol, 2016; Chinese Pharmacopoeia (Huang Qin)

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

Read pending.

Scutellaria Baicalensis is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.

  • Joint comfort and mobilityRandomised trial
  • A healthy inflammatory responseAnimal study
  • Calm and everyday nervous tensionRandomised trial
  • Antioxidant and metal-chelating activityIn vitro study
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI10,025 studies readLabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI10,025 studies readLabs test. IngredientMD verifies.

Questions people ask about Scutellaria Baicalensis.

Is this the same as American Skullcap?
Nope. Related, but different plants. Baikal Skullcap (Scutellaria baicalensis) is the one with the most research for these benefits.
Will it make me sleepy?
It can. Best to try your first dose in the evening. It's more calming than sedating for most, but everyone is different.
Can I take it with my anti-anxiety meds?
Talk to your doctor. Seriously. They can interact, and you don't want to mess with that.
Is it addictive?
No evidence of that. It doesn't work on the same pathways as addictive drugs.
How long should I take it for?
Most studies are short-term (a few months). It's good practice to cycle it, like 3 months on, 1 month off.
Does the plain root powder work?
Extracts are better. The active compounds (like baicalin) are concentrated. Powder is a gamble on potency.
Pairs well with16 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

A botanical mixture containing Boswellia serrata, Commiphora myrrha, propolis and Scutellaria baicalensis was studied together in an animal model, where the authors reported changes in inflammatory gene expression. Both botanicals carry constituents that act on eicosanoid-generating enzymes, so the pairing is mechanistically coherent rather than arbitrary. The measurement is gene expression, a marker, and it was not measured in people.

Propolis appeared alongside Scutellaria baicalensis in the same studied botanical mixture. Propolis flavonoids and the skullcap flavones baicalein and wogonin overlap in their antioxidant chemistry, which is the plausible basis for combining them. What was reported was expression of inflammatory markers in animals, not a clinical outcome in people.

A Scutellaria baicalensis and Crataegus laevigata preparation was tested in humans together with magnesium and chromium, so the combination has been given to people as a single product. The formulation logic is that magnesium supports normal nervous system function while the flavone fraction supplies the botanical component. Because the arms combined all the ingredients, the study cannot separate what each one contributed.

Chromium was included in the same human-tested formulation with Scutellaria baicalensis extract and magnesium. Its presence reflects a formulation convention around normal macronutrient metabolism rather than a demonstrated interaction with the skullcap flavones. Any effect reported belongs to the whole product, not to either part alone.

Scutellaria Baicalensis + probioticsestablished pharmacology

Baicalin, the dominant flavone in the root, is a glucuronide and is poorly absorbed as such. Gut bacterial beta-glucuronidase hydrolyses it to the aglycone baicalein, which is what crosses the intestinal wall. The composition of the resident microbiota therefore sets how much of an oral dose becomes absorbable material.

Scutellaria Baicalensis + inulinestablished pharmacology

Fermentable fibres shift the abundance of bacterial groups that carry beta-glucuronidase activity. Since baicalin needs bacterial deglycosylation before absorption, the fibre background is part of what determines conversion. This is a mechanistic expectation about the shared pathway, not a measured co-administration result.

Scutellaria Baicalensis + quercetinestablished pharmacology

Quercetin and baicalein are both flavonoids cleared largely by glucuronidation and sulfation in the intestinal wall and liver. Given together they draw on the same conjugating capacity, so plasma exposure of one can shift when the other is dosed heavily. The direction depends on dose and timing rather than being fixed.

Curcuminoids and skullcap flavones are both handled by UGT-mediated glucuronidation before elimination. Co-dosing loads the same conjugation route, which can raise the free fraction of either polyphenol. The pairing is common in botanical formulas and the interaction is pharmacokinetic rather than a distinct combined effect.

Scutellaria Baicalensis + ironestablished pharmacology

Baicalein carries adjacent phenolic hydroxyls, the structural arrangement that binds ferric iron tightly. A flavone-rich extract taken with an iron dose can form poorly absorbed complexes in the gut lumen. Separating the two by a couple of hours is the usual formulation answer.

Scutellaria Baicalensis + zincestablished pharmacology

Polyphenols with catechol-type hydroxyls chelate divalent cations including zinc, though less avidly than they bind iron. In practice this matters when a concentrated extract and a mineral dose meet in the same capsule. Spacing the doses removes the question.

Baicalein is poorly water soluble, and phospholipid complexes are a standard way to keep sparingly soluble flavones dispersed through the small intestine. The lecithin contributes no pharmacology of its own here. This is formulation practice with a solubility rationale behind it.

Piperine inhibits intestinal UGT and CYP3A activity, the same conjugation step that clears absorbed baicalein quickly. Adding it to a flavone extract is a deliberate attempt to slow first-pass conjugation. The size of the shift for this particular flavone has not been measured.

Scutellaria root and licorice root appear together in long-standing herbal formulas, where licorice is used as a taste and formulation component. The pairing is documented as practice rather than as a measured interaction. Read it as traditional composition, not as a combined clinical result.

Catechins and skullcap flavones share the same conjugation and efflux routes across the enterocyte. Stacking two concentrated polyphenol extracts changes the exposure of both in ways that depend on dose. Neither the direction nor the magnitude has been measured for this pair.

Scutellaria Baicalensis + vitamin-cestablished pharmacology

Ascorbate reduces flavonoid phenoxyl radicals back to the parent flavone, the same recycling relationship it has with tocopherol. That keeps the flavone fraction in its reduced form for longer in an aqueous environment. It is a chemistry-level relationship, shown in solution rather than in people.

Ginger rhizome is a frequent companion to Scutellaria root in traditional botanical blends. The rationale given is digestive tolerance of a bitter root preparation. No combined measurement supports more than that.

Who should be cautious

Nothing specific on file for Scutellaria Baicalensis. Match the label to the daily amount above, and tell your doctor what you take.

Not medical advice. Show the label to your pharmacist.

What Scutellaria Baicalensis actually does.

Established

The active chemistry of this root is a small family of flavonoids, and baicalin is the one present in the largest amount.

Established

The main compound has a sugar attached that blocks absorption; gut bacteria snip it off so the body can take the compound up.

Established

Once absorbed, the compound is quickly repackaged by the gut wall and liver, so most of what circulates is a conjugated form.

Established

In lab tests its structure grips iron and similar metals. That is the reason given for spacing it apart from mineral supplements.

Grown, 6 steps on record

Where Scutellaria Baicalensis comes from.

The roots are dug up, washed and dried, then soaked in water or alcohol to pull out the active flavonoids. The liquid is concentrated and cleaned up into a powder that is tested so each batch carries a stated amount of baicalin.

Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.

Starts as
Cultivated Scutellaria baicalensis root

Roots of the perennial are lifted after two to three growing seasons, when flavone content in the root has accumulated. Northeast Asia is the main growing region.

Converted by
Washing and drying

Roots are washed, the cork layer is removed, and the material is dried. Drying conditions matter because endogenous plant beta-glucuronidase can hydrolyse baicalin to baicalein in slowly dried or damp roots, shifting the assay profile.

Extracted by
Solvent extraction

Milled root is extracted with hot water or aqueous ethanol. The flavone glycosides partition into the solvent while much of the fibre and starch stays behind.

Purified by
Precipitation or resin capture

Baicalin is commonly recovered by acid precipitation from the aqueous extract, or captured on a macroporous resin and eluted with alcohol. Isolated baicalein is produced by hydrolysing the glucuronide.

Standardised to
Assay to a stated baicalin percentage

The concentrate is assayed by HPLC and blended with a carrier until it meets the declared flavone content.

Ends up as
Dry powder, granulation or phospholipid complex

The standardised concentrate is dried and either encapsulated directly or complexed with phosphatidylcholine for lipid-based delivery.

The forms it comes in.

Scutellaria baicalensis root powderWhole milled root with the native flavone glycoside profile intact, baicalin predominating.Fits Formulas built on a traditional whole-root preparation, and teas or decoctions.Trade-off Flavone content varies with growing region and root age, and the dose of active material per gram is lower than a concentrated extract.
Scutellaria baicalensis extract standardised to baicalinSolvent extraction concentrates the flavone fraction and the extract is assayed to a stated baicalin percentage.Fits Capsules and tablets where a declared flavone content is required for label accuracy.Trade-off Standardising on one marker means the rest of the root matrix is present in whatever proportion the solvent happened to carry.
BaicalinThe purified 7-O-glucuronide, isolated from the root extract rather than presented as a whole extract.Fits Products that want a single defined molecule with a fixed assay.Trade-off Absorption still depends on bacterial deglycosylation, so the purified glycoside carries the same conversion step as the extract.
BaicaleinThe sugar-free aglycone, obtained by hydrolysis of baicalin or by direct isolation.Fits Formulations that want to bypass the bacterial deglycosylation step.Trade-off Poor water solubility and fast conjugation after absorption, so it is usually paired with a solubilising vehicle.
Baicalin phytosome-type complexThe flavone is complexed with phosphatidylcholine to improve dispersion in intestinal fluid.Fits Softgels and lipid-based delivery.Trade-off The phospholipid adds weight, so the flavone load per capsule falls relative to a dry extract.Active and formulation aid
What the strongest studies found

The essence, in one line each.

  1. A Scutellaria and saffron combination improved some self-reported mood measures compared with placebo in adults reporting low mood.Randomised trial. Dormal et al., 2025 (Nutrients). PMID 40077679
  2. An Acacia catechu and Scutellaria baicalensis extract improved performance on some cognitive measures relative to placebo.Randomised trial. Krieger et al., 2025 (Nutritional neuroscience). PMID 39701593
  3. A combination of Scutellaria baicalensis and Crataegus laevigata extract with magnesium and chromium was given to adults and assessed for effects on mood and cognitive measures, with outcomes reported for the whole formulation rather than any single component.Randomised trial. Dodd F et al., 2025 (Journal of Psychopharmacology). PMID 41194549
  4. Scutellaria baicalensis extract fed to transition dairy cows was associated with changes in circulating inflammatory biomarkers and in performance measures.Animal study. Horst EA et al., 2026 (Journal of Dairy Science). PMID 41887512
  5. Dietary Scutellaria baicalensis supplementation in sows was evaluated for milk yield and litter growth performance.Animal study. Feyera T et al., 2026 (Translational Animal Science). PMID 41705272
  6. Post-hatch supplementation with a Scutellaria baicalensis flavonoid preparation, combined with early embryonic thermal programming, was reported to change measured physiological markers in birds.Animal study. Al Amaz S et al., 2025 (Frontiers in Veterinary Science). PMID 39936078
  7. Network pharmacology predictions for Scutellaria baicalensis extract were followed by in vivo testing in birds, with the authors reporting agreement between predicted targets and measured markers.Animal study. Huang P et al., 2026 (Poultry Science). PMID 41855800
  8. A Scutellaria baicalensis polysaccharide fraction fed as an antibiotic alternative was associated with improved growth performance measures in the animals studied.Animal study. Liu S et al., 2026 (Veterinary World). PMID 41822591
  9. Herbal extracts of Scutellaria baicalensis and Lonicera japonica fed together were reported to change performance and physiological measures in birds.Animal study. Sampath V et al., 2025 (Frontiers in Veterinary Science). PMID 41952695
  10. A botanical mixture of Boswellia serrata, Commiphora myrrha, propolis and Scutellaria baicalensis was reported to reduce expression of inflammatory markers in the animals studied.Animal study. Ha D et al., 2026 (Veterinary Medicine and Science). PMID 42057627

These are the studies our verdict leans on, chosen from the 1,197 we read for Scutellaria Baicalensis. The full linked list is below.

Primary evidence

The studies, linked.

3 sources behind our Scutellaria Baicalensis verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.

  1. ClinicalTrials.gov
  2. ClinicalTrials.gov
  3. ClinicalTrials.gov

Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.

Side effects reported to the FDA

Problems people have reported.

Read this carefully. These are 75 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Scutellaria Baicalensis is, not how risky it is. A report is not proof Scutellaria Baicalensis caused anything. It is a signal of what to watch for, nothing more.

Drug Interaction
3
Back Pain
2
Drug-induced Liver Injury
2
Fatigue
2
Hepatic Function Abnormal
2
Nasopharyngitis
2

Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.